Nomura Holdings Inc. Sells 35,463 Shares of Pediatrix Medical Group, Inc. $MD

Key Points

• Nomura Holdings Inc. has reduced its stake in Pediatrix Medical Group by 12%, selling 35,463 shares and retaining 260,456 shares valued at approximately $3.77 million.
• Pediatrix Medical Group reported earnings per share of $0.53 for the last quarter, surpassing analyst expectations by $0.11, though revenue showed a decline of 7.1% year-over-year.
• Brokerage firm Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating, contributing to a consensus rating of "Moderate Buy" among analysts.

Nomura Holdings Inc. lessened its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 12.0% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 260,456 shares of the company's stock after selling 35,463 shares during the period. Nomura Holdings Inc. owned 0.30% of Pediatrix Medical Group worth $3,774,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Boston Partners lifted its position in Pediatrix Medical Group by 1.3% during the 1st quarter. Boston Partners now owns 1,981,889 shares of the company's stock worth $27,990,000 after buying an additional 25,536 shares in the last quarter. Northern Trust Corp raised its stake in shares of Pediatrix Medical Group by 18.0% in the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company's stock worth $12,678,000 after acquiring an additional 147,522 shares during the last quarter. Invesco Ltd. lifted its position in shares of Pediatrix Medical Group by 9.3% during the first quarter. Invesco Ltd. now owns 863,269 shares of the company's stock worth $12,509,000 after purchasing an additional 73,157 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Pediatrix Medical Group by 6.2% during the first quarter. Principal Financial Group Inc. now owns 586,190 shares of the company's stock valued at $8,494,000 after purchasing an additional 34,266 shares during the last quarter. Finally, Nuveen LLC bought a new stake in shares of Pediatrix Medical Group during the first quarter valued at approximately $8,024,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have issued reports on MD. Macquarie upped their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Finally, UBS Group raised their price target on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Pediatrix Medical Group presently has an average rating of "Moderate Buy" and an average price target of $16.75.

Pediatrix Medical Group Trading Up 2.3%

Shares of Pediatrix Medical Group stock traded up $0.38 on Thursday, hitting $16.99. 753,049 shares of the company's stock traded hands, compared to its average volume of 817,854. The firm's 50-day moving average price is $14.40 and its two-hundred day moving average price is $14.12. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The stock has a market capitalization of $1.48 billion, a PE ratio of 13.17 and a beta of 1.30. Pediatrix Medical Group, Inc. has a one year low of $10.06 and a one year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. The business had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm's quarterly revenue was down 7.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.34 earnings per share. On average, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.